patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: NEWS: GILEAD'S LOSS PUTS PLURISTEM & UNITED THERAPEUTICS AHEAD OF THE REST

Another big Pharm company had their hepatitis trials meet disaster and that moved a small company's tech to the front of the line, just like what you described with PSTI.

That other start up stock moved up 20-30 % once the news got out and people became more aware.

Thanks for sharing your information :)

Share
New Message
Please login to post a reply